Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-26 @ 5:14 AM
Study NCT ID:
NCT03425994
Status:
UNKNOWN
Last Update Posted:
2019-08-28
First Post:
2018-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection
Sponsor:
National Taiwan University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-11
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-11
First Submit QC Date:
None
Study First Post Date:
2018-02-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-25
Last Update Post Date:
2019-08-28
Last Update Post Date Type:
ACTUAL